| Pituitary Neuroendocrine Tumor of PIT1-Lineage studied in …STUDIED_INderived22 of 22show fewer |
|---|
| → studied in | NCT00001595recruiting An Investigation of Pituitary Tumors and Related Hypothalmic Disorders · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07463235Phase 3 · recruiting Safety and Potency of a High Cabergoline Dosage in Microprolactinomas · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07268183recruiting How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting Tumors · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06936813active not recruiting The PROMISE Survey · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04106531terminated Validation of a Quality of Life Metric "Prolac-10" · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07045935Phase 4 · recruiting Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03038308Phase 1/Phase 2 · completed Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05236829completed Exercise Capacity and Physical Activity Level in Prolactinoma Patients · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04107480Phase 4 · unknown PRolaCT - Three Prolactinoma RCTs · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03457389NA · unknown Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03474601unknown Seoul National University Pituitary Disease Cohort Study · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00939523Phase 2 · completed Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03717454NA · unknown Dopamine D2 Receptors(D2R) Imaging in Prolactinomas · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03400865NA · unknown Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01504399completed Rhinological Outcomes in Endonasal Pituitary Surgery · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03353025NA · unknown Study on Therapy of Non-invasive Prolactinoma · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01620138Phase 2/Phase 3 · completed Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas · condition mapped PROBABILISTIC · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01775332NA · unknown Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01088763Phase 1 · terminated Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00697814Phase 2 · completed Clomiphene in Males With Prolactinomas and Persistent Hypogonadism · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00460616completed Cardiac Valve Complications in Prolactinomas Treated With Cabergoline · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00481299completed Insulin Resistance in Women With Prolactinoma · condition mapped ALIAS · 22 trials mapped (5 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |